PropertyValue
?:citation
is ?:itemReviewed of
?:keywords
?:mentions
?:text
  • The publication of a Pfizer document in 2022 is the first time that the public have been able to view data from its clinical trials that was submitted for the Covid-19 vaccine’s approval. (en)
rdf:type